Latest / Decera Clinical Education Oncology Podcast
TKIs for Advanced HCC in the Second Line and Beyond
In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss second line treatment of patients with advanced hepatocellular carcinoma. Topics include:
Available agents for the management of advanced hepatocellular carcinoma in the second line
The current role of tyrosine kinase inhibitors in second-line treatment of advanced hepatocellular carcinoma
Ongoing clinical trials in the second-line setting
Presenters:
Josep M. Llovet, MD, PhD, FAASLD
Professor of Medicine
Director, Mount Sinai Liver Cancer Program
Division of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.